A Japanese Lab Just Cracked the 100-Year-Old Insulin Pill Problem — But Can It Survive the Leap From Mice to Humans?
Kumamoto University's DNP peptide technology pushed oral insulin bioavailability to 33–41%, a range previous attempts never reached. In a field littered with a century of failures, this research deserves serious scrutiny — what makes it different, and what does it mean for 537 million diabetes patients worldwide.